Risk Factors Update Summary
- Added "delivery" and "service" to risk factors, impacting timely completion of clinical trials.
- Change in FDA submission dates from "June 2022" to "August 2023" and "second half of 2022."
- Potential delisting from Nasdaq due to failure to meet minimum stockholders' equity requirement.
- Increased risk due to ongoing war and instability following Russia's invasion of Ukraine.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1574094&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.